Acurx Pharmaceuticals Inc...

0.73
-0.05 (-6.05%)
At close: Jan 29, 2025, 3:59 PM
0.73
0.68%
After-hours Jan 29, 2025, 05:25 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a
Operating Income -14.58M -12.09M -12.88M -4.60M -5.93M
Interest Income n/a n/a n/a n/a n/a
Pretax Income -14.58M -12.09M -12.75M -4.60M -5.93M
Net Income -14.58M -12.09M -12.68M -4.60M -5.93M
Selling & General & Admin 8.53M 7.34M 10.78M 2.40M 2.42M
Research & Development 6.04M 4.75M 2.03M 2.20M 3.51M
Other Expenses n/a n/a n/a n/a n/a
Operating Expenses 14.58M 12.09M 12.81M 4.60M 5.93M
Interest Expense n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 14.58M 12.09M 12.81M 4.60M 5.93M
Income Tax n/a -1.22K -66.50K -4.60K -5.93K
Shares Outstanding (Basic) 12.67M 10.82M 10.22M 9.92M 9.92M
Shares Outstanding (Diluted) 12.67M 10.82M 10.22M 9.92M 9.92M
EPS (Basic) -1.15 -1.12 -1.24 -0.46 -0.6
EPS (Diluted) -1.15 -1.12 -1.24 -0.46 -0.6
EBITDA n/a -12.09M n/a -4.60M -5.93M
Depreciation & Amortization 14.58M 12.09M 12.81M 4.60M 5.93M